FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Iovance Bio Gets Priority Review for Melanoma BLA

FDA accepts for priority review an Iovance Biotherapeutics BLA submission for lifileucel, a tumor infiltrating lymphocyte therapy for treating patient...

latest-news-card-1
Human Drugs

Janssen NDA for Pulmonary Hypertension Drug

Janssen submits an NDA to FDA for an investigational combination of Opsumit and Cialis to treat some adults with pulmonary arterial hypertension.

latest-news-card-1
Medical Devices

Think Surgical Gains Clearance for TMINI Robot

FDA clears a Think Surgical 510(k) for its TMINI Miniature Robotic System for performing total knee replacement surgeries.

latest-news-card-1
Federal Register

Guide on Power Morcellator Tissue Containment

Federal Register notice: FDA makes available a final guidance entitled Non-Clinical Performance Assessment of Tissue Containment Systems Used During P...

latest-news-card-1
Human Drugs

Pfizers Marstacimab Meets Phase 3 Goals

Pfizer says its hemophilia drug marstacimab met the primary endpoints in the Phase 3 BASIS trial.

latest-news-card-1
Human Drugs

Akebia Therapeutics Resubmitting Anemia NDA

CDERs Office of New Drugs denies an Akebia Therapeutics dispute resolution request following receipt of a 3/22 complete response letter for vadadustat...

latest-news-card-1
Human Drugs

Suggestions for Oncology Accelerated Approval Guidance

Two stakeholders make recommendations for improving an FDA draft guidance on clinical trial considerations to support accelerated approval of oncology...

latest-news-card-1
Medical Devices

iRhythm Gets Warning Letter on Heart Monitor

FDA sends iRhythm Technologies a Warning Letter that cites violations from an 8/22 agency inspection of the companys Zio heart monitor manufacturing s...

latest-news-card-1
Federal Register

Guide on Diabetes Trial Endpoints

Federal Register notice: FDA releases a draft guidance entitled Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic D...

latest-news-card-1
Federal Register

Guide on Covariate Adjustments in Trials

Federal Register notice: FDA makes available a final guidance entitled Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological...